Menu
  • Join
  • Login
  • Contact
 

Search abstracts / presentations


Sarilumab-associated neutropenia and thrombocytopenia in patients with rheumatic diseases

  • At: Seville (Spain) (2022)
  • Type: Poster
  • Poster code: HMI-025
  • By: PéREZ-PERIáñEZ ORRILLO, Lorenzo (Hospital Universitario Marqués De Valdecilla, Spain)
  • Co-author(s): Dr Lorenzo Pérez-periáñez Orrillo, Pharmacist (Hospital Universitario Marqués De Valdecilla, Santander, Spain)
    Dr Víctor Fernández Martínez, Pharmacist (Hospital Universitario Marqués De Valdecilla, Santander, Spain)
    Dr David Gómez Gómez, Pharmacist (Hospital Universitario Marqués De Valdecilla, Santander, Spain)
    Dr Irene Aragón Gracia, Hospital pharmacy (Hospital Universitario Marqués De Valdecilla, Santander, Spain)
    Dr Marina Bàrbara Ramis Barcelò, Pharmacist (Hospital Universitario Marqués De Valdecilla, Santander, Spain)
    Dr Rosana Lucía Rey Montalbán, Pharmacist (Hospital Universitario Marqués De Valdecilla, Santander, Spain)
    Dr Clara Fernández Martínez, Pharmacist (Hospital Universitario Marqués De Valdecilla, Santander, Spain)
    Dr Marta Valero Domínguez, Hospital pharmacy (Hospital Universitario Marqués De Valdecilla, Santander, Spain)
  • Abstract:


    Aims
    Sarilumab is a human monoclonal antibody that specifically binds to interleukin-6 receptors, blocking different cellular responses mediated by this cytokine, such as proliferation, differentiation and survival in haematopoietic cells. The aim of this study is to analyze the hematological safety profile of sarilumab in outpatient treatment of ..

  • The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 28 September 2023

FIP Congresses